Automating the production of life-saving drugs

Bosch Packaging Technology has developed a new integrated filling line for Porton Biopharma

picture of

Breaking News

GE Healthcare launches automation software for cell therapy

Software has been designed to fit specific requirements to incorporate the platform into existing software and hardware ...

Kite to build new manufacturing plant for CAR-T therapies in the US

The 20-acre site located in Maryland will produce cell therapies for people with cancer

GSK moves to make good on shingles vaccine commitment

British pharma giant invests US$100 million in vaccine manufacturing facility that makes the company’s shingles ...

New enantioselective desymmetrisation strategy uses recombinant pig liver esterases

Enzymicals has established a new compound from the development of an efficient biocatalytic sequential multistep one- ...

Velabs and Chiome team up to discover GPCR antibodies

The collaboration will see Velabs compensated by the Japanese company for the use of its microfluidics-based technology ...

Kiadis acquires CytoSen for synergistic immunology portfolio

CytoSen Therapeutics develops NK-cell therapy, which complements Kiadis’ T-cell therapy portfolio

Supporting precision with precision

As biologics steadily grow in pipeline development and commercialisation, they inherently require precise and ...

Gene therapy uses HIV virus to cure ‘bubble boy’ disease

Therapy has cured 10 infants with no side effects and experts hope this development template will be used for other ...

CPhI North America and iBIO parnership supports women in STEM

Partnership includes US$10,000 donation to fund iBIO STEM programming for girls, plus discounted rates for iBIO members ...

Automating the production of life-saving drugs

Bosch Packaging Technology has developed a new integrated filling line for Porton Biopharma

A new paradigm in vaccines and cancer treatments

Specialist pharmaceutical company N4 Pharma is developing Nuvec, a unique non-viral adjuvant delivery system for ...

Realising the potential of single-use technology

Today’s growing pipeline of biological drugs require production environments that are agile and efficient, writes ...

TTP creates company for new cell sorting technology

The spinout will receive US$ 2.2 million to commercialise the Vortex-Actuated Cell Sorting (VACS) technology and fast- ...

Twist Bioscience puts antibody optimisation potential to use

Partnership to apply antibody optimisation platform to the targeting arm of a bispecific antibody